Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-03-11
Original SEC Filing: Click here

---

Webplus: SVA/20190311/6-K_1/2_EX-99.1/000.htm SEC Original: tv515801_ex99-1.htm
Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common and Series B Preferred Shares announced February 22, 2019. On February 22,

---

---

Webplus: SVA/20190311/6-K_1/1/000.htm SEC Original: tv515801_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-03-11CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200